Medium-Ring Keto Bislactams with Antischistosomal Activity
Journal of Medicinal Chemistry · 24.10.2024 · 67 (20) · 18235-18246
DOI: 10.1021/acs.jmedchem.4c01532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 08.10.2024. Verfasst von Rongguo Ren und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States. Hauptthemen laut MEDLINE: Lactams, Schistosoma mansoni. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
We discovered medium-ring keto bislactams as a new antischistosomal chemotype. The ketone functional group and isoindolinone substructure were required for high antischistosomal activity. Aryl substitution with EWG functional groups decreased the chemical stability. These compounds were relatively polar with the measured LogD7.4 values ranging from 320 μM, and had relatively low cytotoxicities with IC50s ranging from 52 to >390 μM. We identified two compounds with IC50 values < 5 μM against ex vivoSchistosoma mansoni (S. mansoni).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.
- Department of Medical Parasitology and Infection Biology, Swiss Tropical Institute, Socinstrasse 57, Basel CH-4002, Switzerland.
- University of Basel, Basel CH-4003, Switzerland.
- Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
ORCID-Profile: Yuxiang Dong, Susan A Charman, Jonathan L Vennerstrom
Förderung
- NIAID NIH HHS
- Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Ren, R., Leas, D. A., Häberli, C., Cal, M., Chen, G., Katneni, K., Dong, Y., Kaiser, M., Keiser, J., Charman, S. A., & Vennerstrom, J. L. (2024). Medium-Ring Keto Bislactams with Antischistosomal Activity. Journal of Medicinal Chemistry, 67(20), 18235-18246. https://doi.org/10.1021/acs.jmedchem.4c01532
Vancouver
Ren R, Leas DA, Häberli C, Cal M, Chen G, Katneni K, et al. Medium-Ring Keto Bislactams with Antischistosomal Activity. Journal of Medicinal Chemistry. 2024;67(20):18235-18246. doi:10.1021/acs.jmedchem.4c01532
BibTeX
@article{Ren2024,
author = {Ren, Rongguo and Leas, Derek A and Häberli, Cécile and Cal, Monica and Chen, Gong and Katneni, Kasiram and Dong, Yuxiang and Kaiser, Marcel and Keiser, Jennifer and Charman, Susan A and Vennerstrom, Jonathan L},
title = {Medium-Ring Keto Bislactams with Antischistosomal Activity},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {20},
pages = {18235--18246},
doi = {10.1021/acs.jmedchem.4c01532}
}
EUVIMED